Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer

• 收藏
• 分享

专利权人:

Inc.;Syndax Pharmaceuticals

发明人:

Goodenow, Robert,Ordentlich, Peter

申请号：

AU2016235434

公开号：

AU2016235434A1

申请日:

2016.03.18

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

Described herein are methods for the treatment of cancer in a subject. In particular, methods are provided for the treatment of non small cell lung cancer and melanoma with a combination of entinostat and an anti-PD-1 or an anti-PD-L1 antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/